-
2
-
-
84937232628
-
Safety and tolerability of antipsychotic-mood stabilizer cotreatment in the management of acute bipolar disorder: Results from a systematic review and exploratory meta-analysis
-
Galling B, Garcia MA, Osuchukwu U, Hagi K, Correll CU. Safety and tolerability of antipsychotic-mood stabilizer cotreatment in the management of acute bipolar disorder: results from a systematic review and exploratory meta-analysis. Expert Opin Drug Saf. 2015;14:1181-1199.
-
(2015)
Expert Opin Drug Saf
, vol.14
, pp. 1181-1199
-
-
Galling, B.1
Garcia, M.A.2
Osuchukwu, U.3
Hagi, K.4
Correll, C.U.5
-
4
-
-
84860591953
-
Are antipsychotics or antidepressants needed for psychotic depression? A systematic review and meta-analysis of trials comparing antidepressant or antipsychotic monotherapy with combination treatment
-
Farahani A, Correll CU. Are antipsychotics or antidepressants needed for psychotic depression? A systematic review and meta-analysis of trials comparing antidepressant or antipsychotic monotherapy with combination treatment. J Clin Psychiatry. 2012;73:486-496.
-
(2012)
J Clin Psychiatry
, vol.73
, pp. 486-496
-
-
Farahani, A.1
Correll, C.U.2
-
5
-
-
84856466929
-
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
-
De Hert M, Detraux J, van Winkel R, Correll CU. Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol. 2011;8:114-126.
-
(2011)
Nat Rev Endocrinol
, vol.8
, pp. 114-126
-
-
DE Hert, M.1
Detraux, J.2
Van Winkel, R.3
Correll, C.U.4
-
6
-
-
84922900972
-
Cardiovascular and cerebrovascular risk factors and events associated with second-generation antipsychotic compared to antidepressant use in a non-elderly adult sample: Results from a claims-based inception cohort study
-
Correll CU, Joffe BI, Rosen LM, Sullivan TB, Joffe RT. Cardiovascular and cerebrovascular risk factors and events associated with second-generation antipsychotic compared to antidepressant use in a non-elderly adult sample: results from a claims-based inception cohort study. World Psychiatry. 2015;14:56-63.
-
(2015)
World Psychiatry
, vol.14
, pp. 56-63
-
-
Correll, C.U.1
Joffe, B.I.2
Rosen, L.M.3
Sullivan, T.B.4
Joffe, R.T.5
-
7
-
-
84930444696
-
Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder
-
Correll CU, Detraux J, De Lepeleire J, De Hert M. Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry. 2015;14:119-136.
-
(2015)
World Psychiatry
, vol.14
, pp. 119-136
-
-
Correll, C.U.1
Detraux, J.2
De Lepeleire, J.3
DE Hert, M.4
-
8
-
-
0032751075
-
Antipsychoticinduced weight gain: A comprehensive research synthesis
-
Allison DB, Mentore JL, Heo M, et al. Antipsychoticinduced weight gain: a comprehensive research synthesis. Am J Psychiatry. 1999;156:1686-1696.
-
(1999)
Am J Psychiatry
, vol.156
, pp. 1686-1696
-
-
Allison, D.B.1
Mentore, J.L.2
Heo, M.3
-
10
-
-
4344622156
-
Pharmacogenetics of antipsychotic- induced weight gain
-
Correll CU, Malhotra AK. Pharmacogenetics of antipsychotic- induced weight gain. Psychopharmacology (Berl). 2004;174:477-489.
-
(2004)
Psychopharmacology (Berl)
, vol.174
, pp. 477-489
-
-
Correll, C.U.1
Malhotra, A.K.2
-
11
-
-
84888376082
-
Genome-wide association studies of obesity and metabolic syndrome
-
Fall T, Ingelsson E. Genome-wide association studies of obesity and metabolic syndrome. Mol Cell Endocrinol. 2014;382:740-757.
-
(2014)
Mol Cell Endocrinol
, vol.382
, pp. 740-757
-
-
Fall, T.1
Ingelsson, E.2
-
12
-
-
78650472775
-
Pharmacogenetics and antipsychotics: Therapeutic efficacy and side effects prediction
-
Zhang J-P, Malhotra AK. Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects prediction. Expert Opin Drug Metabol Toxicol. 2011;7:9-37.
-
(2011)
Expert Opin Drug Metabol Toxicol
, vol.7
, pp. 9-37
-
-
Zhang, J.-P.1
Malhotra, A.K.2
-
13
-
-
84857356940
-
Pharmacogenetics of antipsychotic-induced weight gain: Review and clinical implications
-
Lett TA, Wallace TJ, Chowdhury NI, Tiwari AK, Kennedy JL, Müller DJ. Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications. Mol Psychiatry. 2012;17:242-266.
-
(2012)
Mol Psychiatry
, vol.17
, pp. 242-266
-
-
Lett, T.A.1
Wallace, T.J.2
Chowdhury, N.I.3
Tiwari, A.K.4
Kennedy, J.L.5
Müller, D.J.6
-
14
-
-
84864342355
-
Pharmacogenetics in psychiatry: Translating research into clinical practice
-
Malhotra AK, Zhang JP, Lencz T. Pharmacogenetics in psychiatry: translating research into clinical practice. Mol Psychiatry. 2012;17:760-769.
-
(2012)
Mol Psychiatry
, vol.17
, pp. 760-769
-
-
Malhotra, A.K.1
Zhang, J.P.2
Lencz, T.3
-
15
-
-
67649148483
-
Pharmacogenetics of antipsychotic response in the CATIE trial: A candidate gene analysis
-
Need AC, Keefe RS, Ge D, Grossman I, Dickson S, McEvoy JP, Goldstein DB. Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. Eur J Hum Genet. 2009;17:946-957.
-
(2009)
Eur J Hum Genet
, vol.17
, pp. 946-957
-
-
Need, A.C.1
Keefe, R.S.2
Ge, D.3
Grossman, I.4
Dickson, S.5
McEvoy, J.P.6
Goldstein, D.B.7
-
16
-
-
70350738289
-
Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents
-
Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA. 2009;302:1765-1773.
-
(2009)
JAMA
, vol.302
, pp. 1765-1773
-
-
Correll, C.U.1
Manu, P.2
Olshanskiy, V.3
Napolitano, B.4
Kane, J.M.5
Malhotra, A.K.6
-
17
-
-
33846305400
-
Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomes
-
Robinson DG, Woerner MG, Napolitano B, et al. Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomes. Am J Psychiatry. 2006;163:2096-2102.
-
(2006)
Am J Psychiatry
, vol.163
, pp. 2096-2102
-
-
Robinson, D.G.1
Woerner, M.G.2
Napolitano, B.3
-
18
-
-
33645944971
-
DRD2 promoter region variation as a predictor of sustained response to antipsychotic medication in first-episode schizophrenia patients
-
Lencz T, Robinson DG, Xu K, et al. DRD2 promoter region variation as a predictor of sustained response to antipsychotic medication in first-episode schizophrenia patients. Am J Psychiatry. 2006;163:529-531.
-
(2006)
Am J Psychiatry
, vol.163
, pp. 529-531
-
-
Lencz, T.1
Robinson, D.G.2
Xu, K.3
-
19
-
-
40949142200
-
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: An open randomised clinical trial
-
Kahn RS, Fleischhacker WW, Boter H, et al. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. Lancet. 2008;371:1085-1097.
-
(2008)
Lancet
, vol.371
, pp. 1085-1097
-
-
Kahn, R.S.1
Fleischhacker, W.W.2
Boter, H.3
-
20
-
-
84865975078
-
Association between common variants near the Melanocortin 4 Receptor Gene and severe antipsychotic drug-induced weight gain
-
Malhotra AK, Correll CU, Chowdhury NI, et al. Association between common variants near the Melanocortin 4 Receptor Gene and severe antipsychotic drug-induced weight gain. Arch Gen Psychiatry. 2012;69:904-912.
-
(2012)
Arch Gen Psychiatry
, vol.69
, pp. 904-912
-
-
Malhotra, A.K.1
Correll, C.U.2
Chowdhury, N.I.3
-
21
-
-
84889351499
-
-
Chichester UK: John Wiley & Sons, Ltd
-
Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to Meta-Analysis. Chichester, UK: John Wiley & Sons, Ltd; 2009.
-
(2009)
Introduction to Meta-Analysis
-
-
Borenstein, M.1
Hedges, L.V.2
Higgins, J.P.T.3
Rothstein, H.R.4
-
22
-
-
0030922816
-
Bias in meta-analysis detected by a simple, graphical test
-
Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634.
-
(1997)
BMJ
, vol.315
, pp. 629-634
-
-
Egger, M.1
Smith, G.D.2
Schneider, M.3
Minder, C.4
-
23
-
-
0442309557
-
A non-parametric "trim and fill" method of assessing publication bias in meta-analysis
-
Duval SJ, Tweedie RL. A non-parametric "trim and fill" method of assessing publication bias in meta-analysis. J Am Stat Assoc. 2000;95:89-98.
-
(2000)
J Am Stat Assoc
, vol.95
, pp. 89-98
-
-
Duval, S.J.1
Tweedie, R.L.2
-
24
-
-
38949094880
-
Assessment of cumulative evidence on genetic associations: Interim guidelines
-
Ioannidis JP, Boffetta P, Little J, et al. Assessment of cumulative evidence on genetic associations: interim guidelines. Int J Epidemiol. 2008;37:120-132.
-
(2008)
Int J Epidemiol
, vol.37
, pp. 120-132
-
-
Ioannidis, J.P.1
Boffetta, P.2
Little, J.3
-
25
-
-
79952395209
-
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
-
DE Hert M, Correll CU, Bobes J, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011;10:52-77.
-
(2011)
World Psychiatry
, vol.10
, pp. 52-77
-
-
DE Hert, M.1
Correll, C.U.2
Bobes, J.3
-
26
-
-
84877996294
-
Metabolic risk factors in first-episode schizophrenia: Baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial
-
Fleischhacker WW, Siu CO, Bodén R, Pappadopulos E, Karayal ON, Kahn RS; EUFEST Study Group. Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial. Int J Neuropsychopharmacol. 2013;16:987-995.
-
(2013)
Int J Neuropsychopharmacol
, vol.16
, pp. 987-995
-
-
Fleischhacker, W.W.1
Siu, C.O.2
Bodén, R.3
Pappadopulos, E.4
Karayal, O.N.5
Kahn, R.S.6
-
27
-
-
84888376082
-
Genome-wide association studies of obesity and metabolic syndrome
-
Fall T, Ingelsson E. Genome-wide association studies of obesity and metabolic syndrome. Mol Cell Endocrinol. 2014;382:740-757.
-
(2014)
Mol Cell Endocrinol
, vol.382
, pp. 740-757
-
-
Fall, T.1
Ingelsson, E.2
-
28
-
-
0038513394
-
Oral administration of the 5-HT2Creceptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia
-
Vickers SP, Easton N, Webster LJ, et al. Oral administration of the 5-HT2Creceptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia. Psychopharmacology (Berl). 2003;167:274-280.
-
(2003)
Psychopharmacology (Berl)
, vol.167
, pp. 274-280
-
-
Vickers, S.P.1
Easton, N.2
Webster, L.J.3
-
29
-
-
77954635020
-
Multicenter, placebo-controlled trial of lorcaserin for weight management
-
Smith SR, Weissman NJ, Anderson CM, et al. Multicenter, placebo-controlled trial of lorcaserin for weight management. N Engl J Med. 2010;363:245-256.
-
(2010)
N Engl J Med
, vol.363
, pp. 245-256
-
-
Smith, S.R.1
Weissman, N.J.2
Anderson, C.M.3
-
30
-
-
7144227374
-
Serotonergic control of the organization of feeding and satiety
-
Simansky KJ. Serotonergic control of the organization of feeding and satiety. Behav Brain Res. 1996;73:37-42.
-
(1996)
Behav Brain Res
, vol.73
, pp. 37-42
-
-
Simansky, K.J.1
-
31
-
-
0030903068
-
RS-102221: A novel high affinity and selective, 5-HT2C receptor antagonist
-
Bonhaus DW, Weinhardt KK, Taylor M, et al. RS-102221: a novel high affinity and selective, 5-HT2C receptor antagonist. Neuropharmacology. 1997;36:621-629.
-
(1997)
Neuropharmacology
, vol.36
, pp. 621-629
-
-
Bonhaus, D.W.1
Weinhardt, K.K.2
Taylor, M.3
-
32
-
-
0028909857
-
Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors
-
Tecott LH, Sun LM, Akana SF, et al. Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors. Nature. 1995;374:542-546.
-
(1995)
Nature
, vol.374
, pp. 542-546
-
-
Tecott, L.H.1
Sun, L.M.2
Akana, S.F.3
-
33
-
-
0031721271
-
Leptinindependent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene
-
Nonogaki K, Strack AM, Dallman MF, Tecott LH. Leptinindependent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene. Nature Med. 1998;4:1152-1156.
-
(1998)
Nature Med
, vol.4
, pp. 1152-1156
-
-
Nonogaki, K.1
Strack, A.M.2
Dallman, M.F.3
Tecott, L.H.4
-
34
-
-
0034103054
-
Identification of polymorphic loci in the promoter region of the serotonin 5-HT2C receptor gene and their association with obesity and type II diabetes
-
Yuan X, Yamada K, Ishiyama-Shigemoto S, Koyama W, Nonaka K. Identification of polymorphic loci in the promoter region of the serotonin 5-HT2C receptor gene and their association with obesity and type II diabetes. Diabetologia. 2000;43:373-376.
-
(2000)
Diabetologia
, vol.43
, pp. 373-376
-
-
Yuan, X.1
Yamada, K.2
Ishiyama-Shigemoto, S.3
Koyama, W.4
Nonaka, K.5
-
35
-
-
14844322355
-
Low gene expression conferred by association of an allele of the 5-HT2C receptor gene with antipsychotic-induced weight gain
-
Buckland PR, Hoogendoorn B, Guy CA, Smith SK, Coleman SL, O'Donovan MC. Low gene expression conferred by association of an allele of the 5-HT2C receptor gene with antipsychotic-induced weight gain. Am J Psychiatry. 2005;162:613-615.
-
(2005)
Am J Psychiatry
, vol.162
, pp. 613-615
-
-
Buckland, P.R.1
Hoogendoorn, B.2
Guy, C.A.3
Smith, S.K.4
Coleman, S.L.5
O'Donovan, M.C.6
-
36
-
-
67849090403
-
Olanzapine-induced weight gain is associated with the -759C/T and -697G/C polymorphisms of the HTR2C gene
-
Godlewska BR, Olajossy-Hilkesberger L, Ciwoniuk M, et al. Olanzapine-induced weight gain is associated with the -759C/T and -697G/C polymorphisms of the HTR2C gene. Pharmacogenomics J. 2009;9:234-241.
-
(2009)
Pharmacogenomics J
, vol.9
, pp. 234-241
-
-
Godlewska, B.R.1
Olajossy-Hilkesberger, L.2
Ciwoniuk, M.3
-
37
-
-
67649446993
-
Focus on HTR2C: A possible suggestion for genetic studies of complex disorders
-
Drago A, Serretti A. Focus on HTR2C: a possible suggestion for genetic studies of complex disorders. Am J Med Genet B Neuropsychiatr Genet. 2009;150B:601-637.
-
(2009)
Am J Med Genet B Neuropsychiatr Genet
, vol.150 B
, pp. 601-637
-
-
Drago, A.1
Serretti, A.2
-
38
-
-
0345690100
-
Half a century of antipsychotics and still a central role for dopamine D2 receptors
-
Kapur S, Mamo D. Half a century of antipsychotics and still a central role for dopamine D2 receptors. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:1081-1090.
-
(2003)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.27
, pp. 1081-1090
-
-
Kapur, S.1
Mamo, D.2
-
39
-
-
0030933979
-
A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia
-
Arinami T, Gao M, Hamaguchi H, Toru M. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol Genet. 1997;6:577-582.
-
(1997)
Hum Mol Genet
, vol.6
, pp. 577-582
-
-
Arinami, T.1
Gao, M.2
Hamaguchi, H.3
Toru, M.4
-
40
-
-
0037267659
-
Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics
-
Ritchie T, Noble EP. Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics. Neurochemical Res. 2003;28:73-82.
-
(2003)
Neurochemical Res
, vol.28
, pp. 73-82
-
-
Ritchie, T.1
Noble, E.P.2
-
41
-
-
77954224633
-
D2 receptor genetic variation and clinical response to antipsychotic drug treatment: A meta-analysis
-
Zhang JP, Lencz T, Malhotra AK. D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis. Am J Psychiatry. 2010;167:763-772.
-
(2010)
Am J Psychiatry
, vol.167
, pp. 763-772
-
-
Zhang, J.P.1
Lencz, T.2
Malhotra, A.K.3
-
42
-
-
70349102541
-
C957T polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity
-
Hirvonen MM, Laakso A, Någren K, Rinne JO, Pohjalainen T, Hietala J. C957T polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity. Synapse. 2009;63:907-912.
-
(2009)
Synapse
, vol.63
, pp. 907-912
-
-
Hirvonen, M.M.1
Laakso, A.2
Någren, K.3
Rinne, J.O.4
Pohjalainen, T.5
Hietala, J.6
-
43
-
-
0037320652
-
Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor
-
Duan J, Wainwright MS, Comeron JM, et al. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet. 2003;12:205-216.
-
(2003)
Hum Mol Genet
, vol.12
, pp. 205-216
-
-
Duan, J.1
Wainwright, M.S.2
Comeron, J.M.3
-
44
-
-
84906349049
-
Dopamine and glucose, obesity, and reward deficiency syndrome
-
Blum K, Thanos PK, Gold MS. Dopamine and glucose, obesity, and reward deficiency syndrome. Front Psychol. 2014;5:919.
-
(2014)
Front Psychol
, vol.5
, pp. 919
-
-
Blum, K.1
Thanos, P.K.2
Gold, M.S.3
-
45
-
-
0026611920
-
Decreased striatal D2 dopamine receptors in obese Zucker rats: Changes during aging
-
Hamdi A, Porter J, Prasad C. Decreased striatal D2 dopamine receptors in obese Zucker rats: changes during aging. Brain Res. 1992;589:338-340.
-
(1992)
Brain Res
, vol.589
, pp. 338-340
-
-
Hamdi, A.1
Porter, J.2
Prasad, C.3
-
46
-
-
38949088656
-
Correlation between body mass index and striatal dopamine transporter availability in healthy volunteers--a SPECT study
-
Chen PS, Yang YK, Yeh TL, et al. Correlation between body mass index and striatal dopamine transporter availability in healthy volunteers--a SPECT study. NeuroImage. 2008;40:275-279.
-
(2008)
NeuroImage
, vol.40
, pp. 275-279
-
-
Chen, P.S.1
Yang, Y.K.2
Yeh, T.L.3
-
47
-
-
12344326514
-
Treatments for schizophrenia: A critical review of pharmacology and mechanisms of action of antipsychotic drugs
-
Miyamoto S, Duncan GE, Marx CE, Lieberman JA. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry. 2005;10:79-104.
-
(2005)
Mol Psychiatry
, vol.10
, pp. 79-104
-
-
Miyamoto, S.1
Duncan, G.E.2
Marx, C.E.3
Lieberman, J.A.4
-
48
-
-
0034179737
-
The sympathetic nervous system and obesity: Role in aetiology and treatment
-
Snitker S, Macdonald I, Ravussin E, Astrup A. The sympathetic nervous system and obesity: role in aetiology and treatment. Obes Rev. 2000;1:5-15.
-
(2000)
Obes Rev
, vol.1
, pp. 5-15
-
-
Snitker, S.1
MacDonald, I.2
Ravussin, E.3
Astrup, A.4
-
49
-
-
0347989317
-
Brown adipose tissue: Function and physiological significance
-
Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev. 2004;84:277-359.
-
(2004)
Physiol Rev
, vol.84
, pp. 277-359
-
-
Cannon, B.1
Nedergaard, J.2
-
50
-
-
0035248116
-
The peripheral sympathetic nervous system in human obesity
-
van Baak MA. The peripheral sympathetic nervous system in human obesity. Obes Rev. 2001;2:3-14.
-
(2001)
Obes Rev
, vol.2
, pp. 3-14
-
-
Van Baak, M.A.1
-
51
-
-
0035982901
-
The alpha 2-adrenergic receptor gene and body fat content and distribution: The HERITAGE Family Study
-
Garenc C, Perusse L, Chagnon YC, et al. The alpha 2-adrenergic receptor gene and body fat content and distribution: the HERITAGE Family Study. Mol Med. 2002;8:88-94.
-
(2002)
Mol Med
, vol.8
, pp. 88-94
-
-
Garenc, C.1
Perusse, L.2
Chagnon, Y.C.3
-
52
-
-
0036119161
-
A C-1291G polymorphism in the alpha2A-adrenergic receptor gene (ADRA2A) promoter is associated with cortisol escape from dexamethasone and elevated glucose levels
-
Rosmond R, Bouchard C, Bjorntorp P. A C-1291G polymorphism in the alpha2A-adrenergic receptor gene (ADRA2A) promoter is associated with cortisol escape from dexamethasone and elevated glucose levels. J Inter Med. 2002;251:252-257.
-
(2002)
J Inter Med
, vol.251
, pp. 252-257
-
-
Rosmond, R.1
Bouchard, C.2
Bjorntorp, P.3
-
53
-
-
80053496677
-
Signalling mechanisms of RhoGTPase regulation by the heterotrimeric G proteins G12 and G13
-
Kozasa T, Hajicek N, Chow CR, Suzuki N. Signalling mechanisms of RhoGTPase regulation by the heterotrimeric G proteins G12 and G13. J Biochem. 2011;150:357-369.
-
(2011)
J Biochem
, vol.150
, pp. 357-369
-
-
Kozasa, T.1
Hajicek, N.2
Chow, C.R.3
Suzuki, N.4
-
54
-
-
17344366286
-
Association of a human G-protein beta3 subunit variant with hypertension
-
Siffert W, Rosskopf D, Siffert G, et al. Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet. 1998;18:45-48.
-
(1998)
Nat Genet
, vol.18
, pp. 45-48
-
-
Siffert, W.1
Rosskopf, D.2
Siffert, G.3
-
55
-
-
43549117072
-
Use of multiple biomarkers to improve the prediction of death from cardiovascular causes
-
Zethelius B, Berglund L, Sundstrom J, et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med. 2008;358:2107-2116.
-
(2008)
N Engl J Med
, vol.358
, pp. 2107-2116
-
-
Zethelius, B.1
Berglund, L.2
Sundstrom, J.3
-
56
-
-
14544299691
-
G protein polymorphisms in hypertension, atherosclerosis, and diabetes
-
Siffert W. G protein polymorphisms in hypertension, atherosclerosis, and diabetes. Annu Rev Med. 2005;56:17-28.
-
(2005)
Annu Rev Med
, vol.56
, pp. 17-28
-
-
Siffert, W.1
-
57
-
-
84908430613
-
Influence of GNB3 C825T polymorphism on the efficacy of antidepressants in the treatment of major depressive disorder: A meta-analysis
-
Hu Q, Zhang SY, Liu F, et al. Influence of GNB3 C825T polymorphism on the efficacy of antidepressants in the treatment of major depressive disorder: a meta-analysis. J Affect Disord. 2014;172C:103-109.
-
(2014)
J Affect Disord
, vol.172 C
, pp. 103-109
-
-
Hu, Q.1
Zhang, S.Y.2
Liu, F.3
-
58
-
-
44349166252
-
Common genetic variation near MC4R is associated with waist circumference and insulin resistance
-
Chambers JC, Elliott P, Zabaneh D, et al. Common genetic variation near MC4R is associated with waist circumference and insulin resistance. Nat Genet. 2008;40:716-718.
-
(2008)
Nat Genet
, vol.40
, pp. 716-718
-
-
Chambers, J.C.1
Elliott, P.2
Zabaneh, D.3
-
59
-
-
44349142294
-
Common variants near MC4R are associated with fat mass, weight and risk of obesity
-
Loos RJ, Lindgren CM, Li S, et al. Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet. 2008;40:768-775.
-
(2008)
Nat Genet
, vol.40
, pp. 768-775
-
-
Loos, R.J.1
Lindgren, C.M.2
Li, S.3
-
60
-
-
62749100569
-
Variants near MC4R are associated with obesity and influence obesity-related quantitative traits in a population of middle-aged people: Studies of 14, 940 Danes
-
Zobel DP, Andreasen CH, Grarup N, et al. Variants near MC4R are associated with obesity and influence obesity-related quantitative traits in a population of middle-aged people: studies of 14, 940 Danes. Diabetes. 2009;58:757-764.
-
(2009)
Diabetes
, vol.58
, pp. 757-764
-
-
Zobel, D.P.1
Andreasen, C.H.2
Grarup, N.3
-
62
-
-
0030889192
-
Targeted disruption of the melanocortin-4 receptor results in obesity in mice
-
Huszar D, Lynch CA, Fairchild-Huntress V, et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 1997;88:131-141.
-
(1997)
Cell
, vol.88
, pp. 131-141
-
-
Huszar, D.1
Lynch, C.A.2
Fairchild-Huntress, V.3
-
63
-
-
84912009341
-
Hormonal regulation of the hypothalamic melanocortin system
-
Kim JD, Leyva S, Diano S. Hormonal regulation of the hypothalamic melanocortin system. Front Physiol. 2014;5:480.
-
(2014)
Front Physiol
, vol.5
, pp. 480
-
-
Kim, J.D.1
Leyva, S.2
Diano, S.3
-
64
-
-
84866666334
-
Unraveling the brain regulation of appetite: Lessons from genetics
-
Yeo GS, Heisler LK. Unraveling the brain regulation of appetite: lessons from genetics. Nature Neurosci. 2012;15:1343-1349.
-
(2012)
Nature Neurosci
, vol.15
, pp. 1343-1349
-
-
Yeo, G.S.1
Heisler, L.K.2
-
65
-
-
0342657747
-
Implications of proopiomelanocortin (POMC) mutations in humans: The POMC deficiency syndrome
-
Krude H, Gruters A. Implications of proopiomelanocortin (POMC) mutations in humans: the POMC deficiency syndrome. Trends Endocrinol Metab. 2000;11:15-22.
-
(2000)
Trends Endocrinol Metab
, vol.11
, pp. 15-22
-
-
Krude, H.1
Gruters, A.2
-
66
-
-
48349113289
-
Common nonsynonymous variants in PCSK1 confer risk of obesity
-
Benzinou M, Creemers JW, Choquet H, et al. Common nonsynonymous variants in PCSK1 confer risk of obesity. Nat Genet. 2008;40:943-945.
-
(2008)
Nat Genet
, vol.40
, pp. 943-945
-
-
Benzinou, M.1
Creemers, J.W.2
Choquet, H.3
-
67
-
-
69449093447
-
Association of variants in the PCSK1 gene with obesity in the EPIC-Norfolk study
-
Kilpelainen TO, Bingham SA, Khaw KT, Wareham NJ, Loos RJ. Association of variants in the PCSK1 gene with obesity in the EPIC-Norfolk study. Hum Mol Genet. 2009;18:3496-3501.
-
(2009)
Hum Mol Genet
, vol.18
, pp. 3496-3501
-
-
Kilpelainen, T.O.1
Bingham, S.A.2
Khaw, K.T.3
Wareham, N.J.4
Loos, R.J.5
-
68
-
-
0037097014
-
Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism
-
Reynolds GP, Zhang ZJ, Zhang XB. Association of antipsychotic drug-induced weight gain with a 5-HT2C receptor gene polymorphism. Lancet. 2002;359:2086-2087.
-
(2002)
Lancet
, vol.359
, pp. 2086-2087
-
-
Reynolds, G.P.1
Zhang, Z.J.2
Zhang, X.B.3
-
69
-
-
31544432529
-
Melanocortin-4 receptors, beta- MSH and leptin: Key elements in the satiety pathway
-
Harrold JA, Williams G. Melanocortin-4 receptors, beta- MSH and leptin: key elements in the satiety pathway. Peptides. 2006;27:365-371.
-
(2006)
Peptides
, vol.27
, pp. 365-371
-
-
Harrold, J.A.1
Williams, G.2
-
70
-
-
84920645334
-
The Promise of Psychiatric Pharmacogenomics
-
Hamilton SP. The Promise of Psychiatric Pharmacogenomics. Biol Psychiatry. 2015;77:29-35.
-
(2015)
Biol Psychiatry
, vol.77
, pp. 29-35
-
-
Hamilton, S.P.1
-
71
-
-
0034785813
-
Genetic dissection of atypical antipsychoticinduced weight gain: Novel preliminary data on the pharmacogenetic puzzle
-
Basile VS, Masellis M, McIntyre RS, Meltzer HY, Lieberman JA, Kennedy JL. Genetic dissection of atypical antipsychoticinduced weight gain: novel preliminary data on the pharmacogenetic puzzle. J Clin Psychiatry. 2001;62(suppl 23):45-66.
-
(2001)
J Clin Psychiatry
, vol.62
, pp. 45-66
-
-
Basile, V.S.1
Masellis, M.2
McIntyre, R.S.3
Meltzer, H.Y.4
Lieberman, J.A.5
Kennedy, J.L.6
-
72
-
-
0037202751
-
759C/T genetic variation of 5HT(2C) receptor and clozapineinduced weight gain
-
Basile VS, Masellis M, De Luca V, Meltzer HY, Kennedy JL. 759C/T genetic variation of 5HT(2C) receptor and clozapineinduced weight gain. Lancet. 2002;360:1790-1791.
-
(2002)
Lancet
, vol.360
, pp. 1790-1791
-
-
Basile, V.S.1
Masellis, M.2
De Luca, V.3
Meltzer, H.Y.4
Kennedy, J.L.5
-
73
-
-
32044467124
-
Pilot study of the G-protein beta3 subunit gene (C825T) polymorphism and clinical response to olanzapine or olanzapine-related weight gain in persons with schizophrenia
-
Bishop JR, Ellingrod VL, Moline J, Miller D. Pilot study of the G-protein beta3 subunit gene (C825T) polymorphism and clinical response to olanzapine or olanzapine-related weight gain in persons with schizophrenia. Med Sci Monit. 2006;12:BR47-BR50.
-
(2006)
Med Sci Monit
, vol.12
, pp. BR47-BR50
-
-
Bishop, J.R.1
Ellingrod, V.L.2
Moline, J.3
Miller, D.4
-
74
-
-
84862895753
-
Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain
-
Brandl EJ, Frydrychowicz C, Tiwari AK, et al. Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain. Prog Neuropsychopharmacol Biol Psychiatry. 2012;38:134-141.
-
(2012)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.38
, pp. 134-141
-
-
Brandl, E.J.1
Frydrychowicz, C.2
Tiwari, A.K.3
-
75
-
-
70350761776
-
Leptin gene -2548G/A variants predict risperidone- associated weight gain in children and adolescents
-
Calarge CA, Ellingrod VL, Zimmerman B, Acion L, Sivitz WI, Schlechte JA. Leptin gene -2548G/A variants predict risperidone- associated weight gain in children and adolescents. Psychiatr Genet. 2009;19:320-327.
-
(2009)
Psychiatr Genet
, vol.19
, pp. 320-327
-
-
Calarge, C.A.1
Ellingrod, V.L.2
Zimmerman, B.3
Acion, L.4
Sivitz, W.I.5
Schlechte, J.A.6
-
76
-
-
84878228310
-
Genetic association study between antipsychotic-induced weight gain and the melanocortin-4 receptor gene
-
Chowdhury NI, Tiwari AK, Souza RP, et al. Genetic association study between antipsychotic-induced weight gain and the melanocortin-4 receptor gene. Pharmacogenomics J. 2013;13:272-279.
-
(2013)
Pharmacogenomics J
, vol.13
, pp. 272-279
-
-
Chowdhury, N.I.1
Tiwari, A.K.2
Souza, R.P.3
-
77
-
-
84873083606
-
Association of the common MC4R rs17782313 polymorphism with antipsychoticrelated weight gain
-
Czerwensky F, Leucht S, Steimer W. Association of the common MC4R rs17782313 polymorphism with antipsychoticrelated weight gain. J Clin Psychopharmacol. 2013;33:74-79.
-
(2013)
J Clin Psychopharmacol
, vol.33
, pp. 74-79
-
-
Czerwensky, F.1
Leucht, S.2
Steimer, W.3
-
78
-
-
84883355708
-
MC4R rs489693: A clinical risk factor for second generation antipsychotic-related weight gain?
-
Czerwensky F, Leucht S, Steimer W. MC4R rs489693: a clinical risk factor for second generation antipsychotic-related weight gain? Int J Neuropsychopharmacol. 2013;16:2103-2109.
-
(2013)
Int J Neuropsychopharmacol
, vol.16
, pp. 2103-2109
-
-
Czerwensky, F.1
Leucht, S.2
Steimer, W.3
-
79
-
-
15744364142
-
Weight gain associated with the -759C/T polymorphism of the 5HT2C receptor and olanzapine
-
Ellingrod VL, Perry PJ, Ringold JC, et al. Weight gain associated with the -759C/T polymorphism of the 5HT2C receptor and olanzapine. Am J Med Genet B Neuropsychiatr Genet. 2005;134B:76-78.
-
(2005)
Am J Med Genet B Neuropsychiatr Genet
, vol.134 B
, pp. 76-78
-
-
Ellingrod, V.L.1
Perry, P.J.2
Ringold, J.C.3
-
80
-
-
34247890009
-
Leptin and leptin receptor gene polymorphisms and increases in body mass index (BMI) from olanzapine treatment in persons with schizophrenia
-
Ellingrod VL, Bishop JR, Moline J, Lin YC, Miller DD. Leptin and leptin receptor gene polymorphisms and increases in body mass index (BMI) from olanzapine treatment in persons with schizophrenia. Psychopharmacol Bull. 2007;40:57-62.
-
(2007)
Psychopharmacol Bull
, vol.40
, pp. 57-62
-
-
Ellingrod, V.L.1
Bishop, J.R.2
Moline, J.3
Lin, Y.C.4
Miller, D.D.5
-
81
-
-
77955058083
-
Polymorphisms of the LEP- and LEPR genes, metabolic profile after prolonged clozapine administration and response to the antidiabetic metformin
-
Fernandez E, Carrizo E, Fernandez V, et al. Polymorphisms of the LEP- and LEPR genes, metabolic profile after prolonged clozapine administration and response to the antidiabetic metformin. Schizophrenia Res. 2010;121:213-217.
-
(2010)
Schizophrenia Res
, vol.121
, pp. 213-217
-
-
Fernandez, E.1
Carrizo, E.2
Fernandez, V.3
-
82
-
-
70349464940
-
The association of olanzapine-induced weight gain with peroxisome proliferator- activated receptor-gamma2 Pro12Ala polymorphism in patients with schizophrenia
-
Herken H, Erdal M, Aydin N, et al. The association of olanzapine-induced weight gain with peroxisome proliferator- activated receptor-gamma2 Pro12Ala polymorphism in patients with schizophrenia. DNA Cell Biol. 2009;28:515-519.
-
(2009)
DNA Cell Biol
, vol.28
, pp. 515-519
-
-
Herken, H.1
Erdal, M.2
Aydin, N.3
-
83
-
-
78650671378
-
Risperidoneinduced weight gain in referred children with autism spectrum disorders is associated with a common polymorphism in the 5-hydroxytryptamine 2C receptor gene
-
Hoekstra PJ, Troost PW, Lahuis BE, et al. Risperidoneinduced weight gain in referred children with autism spectrum disorders is associated with a common polymorphism in the 5-hydroxytryptamine 2C receptor gene. J Child Adolesc Psychopharmacol. 2010;20:473-477.
-
(2010)
J Child Adolesc Psychopharmacol
, vol.20
, pp. 473-477
-
-
Hoekstra, P.J.1
Troost, P.W.2
Lahuis, B.E.3
-
84
-
-
0035052252
-
Genetic variants of the serotonin system and weight change during clozapine treatment
-
Hong CJ, Lin CH, Yu YW, Yang KH, Tsai SJ. Genetic variants of the serotonin system and weight change during clozapine treatment. Pharmacogenetics. 2001;11:265-268.
-
(2001)
Pharmacogenetics
, vol.11
, pp. 265-268
-
-
Hong, C.J.1
Lin, C.H.2
Yu, Y.W.3
Yang, K.H.4
Tsai, S.J.5
-
85
-
-
77952424738
-
Dopamine receptor D2 gene is associated with weight gain in schizophrenic patients under long-term atypical antipsychotic treatment
-
Hong CJ, Liou YJ, Bai YM, Chen TT, Wang YC, Tsai SJ. Dopamine receptor D2 gene is associated with weight gain in schizophrenic patients under long-term atypical antipsychotic treatment. Pharmacogenet Genomics. 2010;20:359-366.
-
(2010)
Pharmacogenet Genomics
, vol.20
, pp. 359-366
-
-
Hong, C.J.1
Liou, Y.J.2
Bai, Y.M.3
Chen, T.T.4
Wang, Y.C.5
Tsai, S.J.6
-
86
-
-
84865743042
-
Pharmacogenomic associations with weight gain in olanzapine treatment of patients without schizophrenia
-
Houston JP, Kohler J, Bishop JR, et al. Pharmacogenomic associations with weight gain in olanzapine treatment of patients without schizophrenia. J Clin Psychiatry. 2012;73:1077-1086.
-
(2012)
J Clin Psychiatry
, vol.73
, pp. 1077-1086
-
-
Houston, J.P.1
Kohler, J.2
Bishop, J.R.3
-
87
-
-
82455162579
-
TNF-alpha -308 G>A polymorphism and weight gain in patients with schizophrenia under long-term clozapine, risperidone or olanzapine treatment
-
Huang HH, Wang YC, Wu CL, et al. TNF-alpha -308 G>A polymorphism and weight gain in patients with schizophrenia under long-term clozapine, risperidone or olanzapine treatment. Neurosci Lett. 2011;504:277-280.
-
(2011)
Neurosci Lett
, vol.504
, pp. 277-280
-
-
Huang, H.H.1
Wang, Y.C.2
Wu, C.L.3
-
88
-
-
38349056887
-
Possible association between the -2548A/G polymorphism of the leptin gene and olanzapine-induced weight gain
-
Kang SG, Lee HJ, Park YM, et al. Possible association between the -2548A/G polymorphism of the leptin gene and olanzapine-induced weight gain. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:160-163.
-
(2008)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.32
, pp. 160-163
-
-
Kang, S.G.1
Lee, H.J.2
Park, Y.M.3
-
89
-
-
50449094308
-
The influence of 5-HT(2C) and MDR1 genetic polymorphisms on antipsychotic-induced weight gain in female schizophrenic patients
-
Kuzman MR, Medved V, Bozina N, Hotujac L, Sain I, Bilusic H. The influence of 5-HT(2C) and MDR1 genetic polymorphisms on antipsychotic-induced weight gain in female schizophrenic patients. Psychiatry Res. 2008;160:308-315.
-
(2008)
Psychiatry Res
, vol.160
, pp. 308-315
-
-
Kuzman, M.R.1
Medved, V.2
Bozina, N.3
Hotujac, L.4
Sain, I.5
Bilusic, H.6
-
90
-
-
79151474615
-
Association study of MDR1 and 5-HT2C genetic polymorphisms and antipsychotic-induced metabolic disturbances in female patients with schizophrenia
-
Kuzman MR, Medved V, Bozina N, Grubišin J, Jovanovic N, Sertic J. Association study of MDR1 and 5-HT2C genetic polymorphisms and antipsychotic-induced metabolic disturbances in female patients with schizophrenia. Pharmacogenomics J. 2011;11:35-44.
-
(2011)
Pharmacogenomics J
, vol.11
, pp. 35-44
-
-
Kuzman, M.R.1
Medved, V.2
Bozina, N.3
Grubišin, J.4
Jovanovic, N.5
Sertic, J.6
-
91
-
-
75549088045
-
Pharmacogenetics and olanzapine treatment: CYP1A2∗1F and serotonergic polymorphisms influence therapeutic outcome
-
Laika B, Leucht S, Heres S, Schneider H, Steimer W. Pharmacogenetics and olanzapine treatment: CYP1A2∗1F and serotonergic polymorphisms influence therapeutic outcome. Pharmacogenomics J. 2010;10:20-29.
-
(2010)
Pharmacogenomics J
, vol.10
, pp. 20-29
-
-
Laika, B.1
Leucht, S.2
Heres, S.3
Schneider, H.4
Steimer, W.5
-
92
-
-
33646683308
-
Risperidone-related weight gain: Genetic and nongenetic predictors
-
Lane HY, Liu YC, Huang CL, et al. Risperidone-related weight gain: genetic and nongenetic predictors. J Clin Psychopharmacol. 2006;26:128-134.
-
(2006)
J Clin Psychopharmacol
, vol.26
, pp. 128-134
-
-
Lane, H.Y.1
Liu, Y.C.2
Huang, C.L.3
-
93
-
-
60549089825
-
Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: Perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?
-
Le Hellard S, Theisen FM, Haberhausen M, et al. Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects? Mol Psychiatry. 2009;14:308-317.
-
(2009)
Mol Psychiatry
, vol.14
, pp. 308-317
-
-
Le Hellard, S.1
Theisen, F.M.2
Haberhausen, M.3
-
94
-
-
77955919157
-
DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophrenia
-
Lencz T, Robinson DG, Napolitano B, et al. DRD2 promoter region variation predicts antipsychotic-induced weight gain in first episode schizophrenia. Pharmacogenet Genomics. 2010;20:569-572.
-
(2010)
Pharmacogenet Genomics
, vol.20
, pp. 569-572
-
-
Lencz, T.1
Robinson, D.G.2
Napolitano, B.3
-
95
-
-
33749850384
-
The relationship between P-glycoprotein (PGP) polymorphisms and response to olanzapine treatment in schizophrenia
-
Lin YC, Ellingrod VL, Bishop JR, Miller DD. The relationship between P-glycoprotein (PGP) polymorphisms and response to olanzapine treatment in schizophrenia. Ther Drug Monit. 2006;28:668-672.
-
(2006)
Ther Drug Monit
, vol.28
, pp. 668-672
-
-
Lin, Y.C.1
Ellingrod, V.L.2
Bishop, J.R.3
Miller, D.D.4
-
96
-
-
12944265464
-
Clozapine-induced weight gain associated with the 5HT2C receptor -759C/T polymorphism
-
Miller DD, Ellingrod VL, Holman TL, Buckley PF, Arndt S. Clozapine-induced weight gain associated with the 5HT2C receptor -759C/T polymorphism. Am J Med Genet B Neuropsychiatr Genet. 2005;133B:97-100.
-
(2005)
Am J Med Genet B Neuropsychiatr Genet
, vol.133 B
, pp. 97-100
-
-
Miller, D.D.1
Ellingrod, V.L.2
Holman, T.L.3
Buckley, P.F.4
Arndt, S.5
-
97
-
-
77955129795
-
Endocannabinoid Pro129Thr FAAH functional polymorphism but not 1359G/A CNR1 polymorphism is associated with antipsychotic-induced weight gain
-
Monteleone P, Milano W, Petrella C, Canestrelli B, Maj M. Endocannabinoid Pro129Thr FAAH functional polymorphism but not 1359G/A CNR1 polymorphism is associated with antipsychotic-induced weight gain. J Clin Psychopharmacol. 2010;30:441-445.
-
(2010)
J Clin Psychopharmacol
, vol.30
, pp. 441-445
-
-
Monteleone, P.1
Milano, W.2
Petrella, C.3
Canestrelli, B.4
Maj, M.5
-
98
-
-
44449098227
-
-2548G/A functional polymorphism in the promoter region of leptin gene and antipsychotic agent-induced weight gain in schizophrenic patients: A study of nuclear family-based association
-
Mou XD, Zhang ZJ, Zhang XR, Shi JB, Sun J. [-2548G/A functional polymorphism in the promoter region of leptin gene and antipsychotic agent-induced weight gain in schizophrenic patients: a study of nuclear family-based association]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2008;33:316-320.
-
(2008)
Zhong Nan da Xue Xue Bao Yi Xue Ban
, vol.33
, pp. 316-320
-
-
Mou, X.D.1
Zhang, Z.J.2
Zhang, X.R.3
Shi, J.B.4
Sun, J.5
-
99
-
-
20144388485
-
The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia
-
Müller DJ, Klempan TA, De Luca V, et al. The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia. Neurosci Lett. 2005;379:81-89.
-
(2005)
Neurosci Lett
, vol.379
, pp. 81-89
-
-
Müller, D.J.1
Klempan, T.A.2
De Luca, V.3
-
100
-
-
84858996108
-
Systematic analysis of dopamine receptor genes (DRD1-DRD5) in antipsychoticinduced weight gain
-
Müller DJ, Zai CC, Sicard M, et al. Systematic analysis of dopamine receptor genes (DRD1-DRD5) in antipsychoticinduced weight gain. Pharmacogenomics J. 2012;12:156-164.
-
(2012)
Pharmacogenomics J
, vol.12
, pp. 156-164
-
-
Müller, D.J.1
Zai, C.C.2
Sicard, M.3
-
101
-
-
49149108655
-
SNAP-25 gene polymorphisms and weight gain in schizophrenic patients
-
Musil R, Spellmann I, Riedel M, et al. SNAP-25 gene polymorphisms and weight gain in schizophrenic patients. J Psychiatr Res. 2008;42:963-970.
-
(2008)
J Psychiatr Res
, vol.42
, pp. 963-970
-
-
Musil, R.1
Spellmann, I.2
Riedel, M.3
-
102
-
-
77952924290
-
Association of HTR2C, but not LEP or INSIG2, genes with antipsychoticinduced weight gain in a German sample
-
Opgen-Rhein C, Brandl EJ, Muller DJ, et al. Association of HTR2C, but not LEP or INSIG2, genes with antipsychoticinduced weight gain in a German sample. Pharmacogenomics. 2010;11:773-780.
-
(2010)
Pharmacogenomics
, vol.11
, pp. 773-780
-
-
Opgen-Rhein, C.1
Brandl, E.J.2
Muller, D.J.3
-
103
-
-
33745013199
-
Weight gain associated with the alpha2a-adrenergic receptor -1, 291 C/G polymorphism and olanzapine treatment
-
Park YM, Chung YC, Lee SH, et al. Weight gain associated with the alpha2a-adrenergic receptor -1, 291 C/G polymorphism and olanzapine treatment. Am J Med Genet B Neuropsychiatr Genet. 2006;141B:394-397.
-
(2006)
Am J Med Genet B Neuropsychiatr Genet
, vol.141 B
, pp. 394-397
-
-
Park, Y.M.1
Chung, Y.C.2
Lee, S.H.3
-
104
-
-
38349035863
-
Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and olanzapine-induced weight gain among Korean schizophrenic patients
-
Park YM, Cho JH, Kang SG, et al. Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and olanzapine-induced weight gain among Korean schizophrenic patients. J Clin Pharm Ther. 2008;33:55-60.
-
(2008)
J Clin Pharm Ther
, vol.33
, pp. 55-60
-
-
Park, Y.M.1
Cho, J.H.2
Kang, S.G.3
-
105
-
-
64249151960
-
G-protein beta3 subunit gene 825C/T polymorphism is not associated with olanzapine- induced weight gain in Korean schizophrenic patients
-
Park YM, Chung YC, Lee SH, et al. G-protein beta3 subunit gene 825C/T polymorphism is not associated with olanzapine- induced weight gain in Korean schizophrenic patients. Psychiatry Investig. 2009;6:39-43.
-
(2009)
Psychiatry Investig
, vol.6
, pp. 39-43
-
-
Park, Y.M.1
Chung, Y.C.2
Lee, S.H.3
-
106
-
-
79960835205
-
Cannabinoid type 1 receptor gene polymorphisms are not associated with olanzapine-induced weight gain
-
Park YM, Choi JE, Kang SG, et al. Cannabinoid type 1 receptor gene polymorphisms are not associated with olanzapine-induced weight gain. Hum Psychopharmacol. 2011;26:332-337.
-
(2011)
Hum Psychopharmacol
, vol.26
, pp. 332-337
-
-
Park, Y.M.1
Choi, J.E.2
Kang, S.G.3
-
107
-
-
78649362142
-
Effect of FTO, SH2B1, LEP, and LEPR polymorphisms on weight gain associated with antipsychotic treatment
-
Perez-Iglesias R, Mata I, Amado JA, et al. Effect of FTO, SH2B1, LEP, and LEPR polymorphisms on weight gain associated with antipsychotic treatment. J Clin Psychopharmacol. 2010;30:661-666.
-
(2010)
J Clin Psychopharmacol
, vol.30
, pp. 661-666
-
-
Perez-Iglesias, R.1
Mata, I.2
Amado, J.A.3
-
108
-
-
59149084186
-
DRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain
-
Popp J, Leucht S, Heres S, Steimer W. DRD4 48 bp VNTR but not 5-HT 2C Cys23Ser receptor polymorphism is related to antipsychotic-induced weight gain. Pharmacogenomics J. 2009;9:71-77.
-
(2009)
Pharmacogenomics J
, vol.9
, pp. 71-77
-
-
Popp, J.1
Leucht, S.2
Heres, S.3
Steimer, W.4
-
109
-
-
0038474172
-
Polymorphism of the promoter region of the serotonin 5-HT(2C) receptor gene and clozapine-induced weight gain
-
Reynolds GP, Zhang Z, Zhang X. Polymorphism of the promoter region of the serotonin 5-HT(2C) receptor gene and clozapine-induced weight gain. Am J Psychiatry. 2003;160:677-679.
-
(2003)
Am J Psychiatry
, vol.160
, pp. 677-679
-
-
Reynolds, G.P.1
Zhang, Z.2
Zhang, X.3
-
110
-
-
84878829550
-
The obesity risk gene FTO influences body mass in chronic schizophrenia but not initial antipsychotic drug-induced weight gain in first-episode patients
-
Reynolds GP, Yevtushenko OO, Gordon S, Arranz B, San L, Cooper SJ. The obesity risk gene FTO influences body mass in chronic schizophrenia but not initial antipsychotic drug-induced weight gain in first-episode patients. Int J Neuropsychopharmacol. 2013;16:1421-1425.
-
(2013)
Int J Neuropsychopharmacol
, vol.16
, pp. 1421-1425
-
-
Reynolds, G.P.1
Yevtushenko, O.O.2
Gordon, S.3
Arranz, B.4
San, L.5
Cooper, S.J.6
-
111
-
-
38349027801
-
Association study of -2548A/g polymorphism of leptin gene with antipsychotics-induced weight gain
-
Ryu S, Jang WS, Cho EY, Kim SK, Lee D, Hong KS. Association study of -2548A/g polymorphism of leptin gene with antipsychotics-induced weight gain. Korean J Psychopharmacol. 2006;17:423-428.
-
(2006)
Korean J Psychopharmacol
, vol.17
, pp. 423-428
-
-
Ryu, S.1
Jang, W.S.2
Cho, E.Y.3
Kim, S.K.4
Lee, D.5
Hong, K.S.6
-
112
-
-
33947512695
-
-759 C/T polymorphism of 5-HT2C receptor gene and early phase weight gain associated with antipsychotic drug treatment
-
Ryu S, Cho EY, Park T, et al. -759 C/T polymorphism of 5-HT2C receptor gene and early phase weight gain associated with antipsychotic drug treatment. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31:673-677.
-
(2007)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.31
, pp. 673-677
-
-
Ryu, S.1
Cho, E.Y.2
Park, T.3
-
113
-
-
44449133218
-
Association of HTR2C-759C/T and -697G/C polymorphisms with antipsychotic agent-induced weight gain
-
Shao P, Zhao JP, Chen JD, Wu RR, He YQ. [Association of HTR2C-759C/T and -697G/C polymorphisms with antipsychotic agent-induced weight gain]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2008;33:312-315.
-
(2008)
Zhong Nan da Xue Xue Bao Yi Xue Ban
, vol.33
, pp. 312-315
-
-
Shao, P.1
Zhao, J.P.2
Chen, J.D.3
Wu, R.R.4
He, Y.Q.5
-
114
-
-
84893198055
-
Fat mass- and obesity-associated (FTO) gene and antipsychotic-induced weight gain: An association study
-
Shing EC, Tiwari AK, Brandl EJ, et al. Fat mass- and obesity-associated (FTO) gene and antipsychotic-induced weight gain: an association study. Neuropsychobiology. 2014;69:59-63.
-
(2014)
Neuropsychobiology
, vol.69
, pp. 59-63
-
-
Shing, E.C.1
Tiwari, A.K.2
Brandl, E.J.3
-
115
-
-
78649711976
-
Polymorphisms of the HTR2C gene and antipsychotic-induced weight gain: An update and meta-analysis
-
Sicard MN, Zai CC, Tiwari AK, et al. Polymorphisms of the HTR2C gene and antipsychotic-induced weight gain: an update and meta-analysis. Pharmacogenomics. 2010;11:1561-1571.
-
(2010)
Pharmacogenomics
, vol.11
, pp. 1561-1571
-
-
Sicard, M.N.1
Zai, C.C.2
Tiwari, A.K.3
-
116
-
-
70449510603
-
Association of the alpha 2A adrenergic receptor -1291C/G polymorphism and antipsychotic-induced weight gain in European-Americans
-
Sickert L, Müller DJ, Tiwari AK, et al. Association of the alpha 2A adrenergic receptor -1291C/G polymorphism and antipsychotic-induced weight gain in European-Americans. Pharmacogenomics. 2009;10:1169-1176.
-
(2009)
Pharmacogenomics
, vol.10
, pp. 1169-1176
-
-
Sickert, L.1
Müller, D.J.2
Tiwari, A.K.3
-
117
-
-
84928788133
-
Fat-mass and obesity-associated gene polymorphisms and weight gain after risperidone treatment in first episode schizophrenia
-
Song X, Pang L, Feng Y, et al. Fat-mass and obesity-associated gene polymorphisms and weight gain after risperidone treatment in first episode schizophrenia. Behav Brain Funct. 2014;10:35.
-
(2014)
Behav Brain Funct
, vol.10
, pp. 35
-
-
Song, X.1
Pang, L.2
Feng, Y.3
-
118
-
-
56449085151
-
Association of antipsychotic induced weight gain and body mass index with GNB3 gene: A meta-analysis
-
Souza RP, De Luca V, Muscettola G, et al. Association of antipsychotic induced weight gain and body mass index with GNB3 gene: a meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:1848-1853.
-
(2008)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.32
, pp. 1848-1853
-
-
Souza, R.P.1
De Luca, V.2
Muscettola, G.3
-
119
-
-
84897901955
-
Methylenetetrahydrofolate reductase (MTHFR) 677C/T polymorphism is associated with antipsychotic-induced weight gain in first-episode schizophrenia
-
Srisawat U, Reynolds GP, Zhang ZJ, et al. Methylenetetrahydrofolate reductase (MTHFR) 677C/T polymorphism is associated with antipsychotic-induced weight gain in first-episode schizophrenia. Int J Neuropsychopharmacol. 2014;17:485-490.
-
(2014)
Int J Neuropsychopharmacol
, vol.17
, pp. 485-490
-
-
Srisawat, U.1
Reynolds, G.P.2
Zhang, Z.J.3
-
120
-
-
84859791325
-
Peroxisome proliferatoractivated receptor gamma (PPARG) Pro12Ala: Lack of association with weight gain in psychiatric inpatients treated with olanzapine or clozapine
-
Staeker J, Leucht S, Steimer W. Peroxisome proliferatoractivated receptor gamma (PPARG) Pro12Ala: lack of association with weight gain in psychiatric inpatients treated with olanzapine or clozapine. Mol Diagn Ther. 2012;16:93-98.
-
(2012)
Mol Diagn Ther
, vol.16
, pp. 93-98
-
-
Staeker, J.1
Leucht, S.2
Steimer, W.3
-
121
-
-
17644394540
-
Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis
-
Templeman LA, Reynolds GP, Arranz B, San L. Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis. Pharmacogenet Genomics. 2005;15:195-200.
-
(2005)
Pharmacogenet Genomics
, vol.15
, pp. 195-200
-
-
Templeman, L.A.1
Reynolds, G.P.2
Arranz, B.3
San, L.4
-
122
-
-
4644225416
-
Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and clozapine-induced weight gain among German schizophrenic individuals
-
Theisen FM, Hinney A, Bromel T, et al. Lack of association between the -759C/T polymorphism of the 5-HT2C receptor gene and clozapine-induced weight gain among German schizophrenic individuals. Psychiatr Genet. 2004;14:139-142.
-
(2004)
Psychiatr Genet
, vol.14
, pp. 139-142
-
-
Theisen, F.M.1
Hinney, A.2
Bromel, T.3
-
123
-
-
73449115292
-
Absence of weight gain association with the HTR2C -759C/T polymorphism in patients with schizophrenia treated with iloperidone
-
Thompson A, Lavedan C, Volpi S. Absence of weight gain association with the HTR2C -759C/T polymorphism in patients with schizophrenia treated with iloperidone. Psychiatry Res. 2010;175:271-273.
-
(2010)
Psychiatry Res
, vol.175
, pp. 271-273
-
-
Thompson, A.1
Lavedan, C.2
Volpi, S.3
-
124
-
-
77950902489
-
Association study of polymorphisms in insulin induced gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients
-
Tiwari AK, Zai CC, Meltzer HY, Lieberman JA, Müller DJ, Kennedy JL. Association study of polymorphisms in insulin induced gene 2 (INSIG2) with antipsychotic-induced weight gain in European and African-American schizophrenia patients. Hum Psychopharmacol. 2010;25:253-259.
-
(2010)
Hum Psychopharmacol
, vol.25
, pp. 253-259
-
-
Tiwari, A.K.1
Zai, C.C.2
Meltzer, H.Y.3
Lieberman, J.A.4
Müller, D.J.5
Kennedy, J.L.6
-
125
-
-
77951098236
-
A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia
-
Tiwari AK, Zai CC, Likhodi O, et al. A common polymorphism in the cannabinoid receptor 1 (CNR1) gene is associated with antipsychotic-induced weight gain in Schizophrenia. Neuropsychopharmacology. 2010;35:1315-1324.
-
(2010)
Neuropsychopharmacology
, vol.35
, pp. 1315-1324
-
-
Tiwari, A.K.1
Zai, C.C.2
Likhodi, O.3
-
126
-
-
0037202751
-
CH. -759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain
-
Tsai SJ, Hong CJ, Yu YW, Lin CH. -759C/T genetic variation of 5HT(2C) receptor and clozapine-induced weight gain. Lancet. 2002;360:1790.
-
(2002)
Lancet
, vol.360
, pp. 1790
-
-
Tsai, S.J.1
Hong, C.J.2
Lin, Y.Yw.3
-
127
-
-
0242583205
-
No association of tumor necrosis factor alpha gene polymorphisms with schizophrenia or response to clozapine
-
Tsai SJ, Hong CJ, Yu YW, Lin CH, Liu LL. No association of tumor necrosis factor alpha gene polymorphisms with schizophrenia or response to clozapine. Schizophr Res. 2003;65:27-32.
-
(2003)
Schizophr Res
, vol.65
, pp. 27-32
-
-
Tsai, S.J.1
Hong, C.J.2
Yu, Y.W.3
Lin, C.H.4
Liu, L.L.5
-
128
-
-
2642586378
-
Association study of adrenergic beta3 receptor (Trp64Arg) and G-protein beta3 subunit gene (C825T) polymorphisms and weight change during clozapine treatment
-
Tsai SJ, Yu YW, Lin CH, Wang YC, Chen JY, Hong CJ. Association study of adrenergic beta3 receptor (Trp64Arg) and G-protein beta3 subunit gene (C825T) polymorphisms and weight change during clozapine treatment. Neuropsychobiology. 2004;50:37-40.
-
(2004)
Neuropsychobiology
, vol.50
, pp. 37-40
-
-
Tsai, S.J.1
Yu, Y.W.2
Lin, C.H.3
Wang, Y.C.4
Chen, J.Y.5
Hong, C.J.6
-
129
-
-
84855875337
-
Association study of brain-derived neurotrophic factor gene polymorphisms and body weight change in schizophrenic patients under long-term atypical antipsychotic treatment
-
Tsai A, Liou YJ, Hong CJ, Wu CL, Tsai SJ, Bai YM. Association study of brain-derived neurotrophic factor gene polymorphisms and body weight change in schizophrenic patients under long-term atypical antipsychotic treatment. Neuromolecular Med. 2011;13:328-333.
-
(2011)
Neuromolecular Med
, vol.13
, pp. 328-333
-
-
Tsai, A.1
Liou, Y.J.2
Hong, C.J.3
Wu, C.L.4
Tsai, S.J.5
Bai, Y.M.6
-
130
-
-
52649105994
-
Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: A cohort study
-
Ujike H, Nomura A, Morita Y, et al. Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: a cohort study. J Clin Psychiatry. 2008;69:1416-1422.
-
(2008)
J Clin Psychiatry
, vol.69
, pp. 1416-1422
-
-
Ujike, H.1
Nomura, A.2
Morita, Y.3
-
131
-
-
77955471578
-
MTHFR genotype and differential evolution of metabolic parameters after initiation of a second generation antipsychotic: An observational study
-
van Winkel R, Moons T, Peerbooms O, et al. MTHFR genotype and differential evolution of metabolic parameters after initiation of a second generation antipsychotic: an observational study. Int Clin Psychopharmacol. 2010;25:270-276.
-
(2010)
Int Clin Psychopharmacol
, vol.25
, pp. 270-276
-
-
Van Winkel, R.1
Moons, T.2
Peerbooms, O.3
-
132
-
-
25144477595
-
Polymorphism of the adrenergic receptor alpha 2a -1291C>G genetic variation and clozapine-induced weight gain
-
Wang YC, Bai YM, Chen JY, Lin CC, Lai IC, Liou YJ. Polymorphism of the adrenergic receptor alpha 2a -1291C>G genetic variation and clozapine-induced weight gain. J Neural Transm (Vienna). 2005;112:1463-1468.
-
(2005)
J Neural Transm (Vienna)
, vol.112
, pp. 1463-1468
-
-
Wang, Y.C.1
Bai, Y.M.2
Chen, J.Y.3
Lin, C.C.4
Lai, I.C.5
Liou, Y.J.6
-
133
-
-
25144497419
-
C825T polymorphism in the human G protein beta3 subunit gene is associated with long-term clozapine treatment-induced body weight change in the Chinese population
-
Wang YC, Bai YM, Chen JY, Lin CC, Lai IC, Liou YJ. C825T polymorphism in the human G protein beta3 subunit gene is associated with long-term clozapine treatment-induced body weight change in the Chinese population. Pharmacogenet Genomics. 2005;15:743-748.
-
(2005)
Pharmacogenet Genomics
, vol.15
, pp. 743-748
-
-
Wang, Y.C.1
Bai, Y.M.2
Chen, J.Y.3
Lin, C.C.4
Lai, I.C.5
Liou, Y.J.6
-
134
-
-
77953937453
-
Genetic association between TNF-alpha -308 G>A polymorphism and longitudinal weight change during clozapine treatment
-
Wang YC, Bai YM, Chen JY, Lin CC, Lai IC, Liou YJ. Genetic association between TNF-alpha -308 G>A polymorphism and longitudinal weight change during clozapine treatment. Hum Psychopharmacol. 2010;25:303-309.
-
(2010)
Hum Psychopharmacol
, vol.25
, pp. 303-309
-
-
Wang, Y.C.1
Bai, Y.M.2
Chen, J.Y.3
Lin, C.C.4
Lai, I.C.5
Liou, Y.J.6
-
135
-
-
84864510413
-
The role of brain-derived neurotrophic factor (BDNF) gene variants in antipsychotic response and antipsychotic-induced weight gain
-
Zai GC, Zai CC, Chowdhury NI, et al. The role of brain-derived neurotrophic factor (BDNF) gene variants in antipsychotic response and antipsychotic-induced weight gain. Prog Neuropsychopharmacol Biol Psychiatry. 2012;39:96-101.
-
(2012)
Prog Neuropsychopharmacol Biol Psychiatry
, vol.39
, pp. 96-101
-
-
Zai, G.C.1
Zai, C.C.2
Chowdhury, N.I.3
-
136
-
-
0037337321
-
No association of antipsychotic agent-induced weight gain with a da receptor gene polymorphism and therapeutic response
-
Zhang ZJ, Yao ZJ, Zhang XB, et al. No association of antipsychotic agent-induced weight gain with a DA receptor gene polymorphism and therapeutic response. Acta Pharmacol Sinica. 2003;24:235-240.
-
(2003)
Acta Pharmacol Sinica
, vol.24
, pp. 235-240
-
-
Zhang, Z.J.1
Yao, Z.J.2
Zhang, X.B.3
-
137
-
-
2342525335
-
Association of -2548G/A functional polymorphism in the promoter region of leptin gene with antipsychotic agent-induced weight gain
-
Zhang ZJ, Yao ZJ, Mou XD, et al. [Association of -2548G/A functional polymorphism in the promoter region of leptin gene with antipsychotic agent-induced weight gain]. Zhonghua Yi Xue Za Zhi. 2003;83:2119-2123.
-
(2003)
Zhonghua Yi Xue Za Zhi
, vol.83
, pp. 2119-2123
-
-
Zhang, Z.J.1
Yao, Z.J.2
Mou, X.D.3
-
138
-
-
34248592726
-
Association of clozapine- induced weight gain with a polymorphism in the leptin promoter region in patients with chronic schizophrenia in a Chinese population
-
Zhang XY, Tan YL, Zhou DF, et al. Association of clozapine- induced weight gain with a polymorphism in the leptin promoter region in patients with chronic schizophrenia in a Chinese population. J Clin Psychopharmacol. 2007;27:246-251.
-
(2007)
J Clin Psychopharmacol
, vol.27
, pp. 246-251
-
-
Zhang, X.Y.1
Tan, Y.L.2
Zhou, D.F.3
-
139
-
-
47249138191
-
BDNF levels and genotype are associated with antipsychotic-induced weight gain in patients with chronic schizophrenia
-
Zhang XY, Zhou DF, Wu GY, et al. BDNF levels and genotype are associated with antipsychotic-induced weight gain in patients with chronic schizophrenia. Neuropsychopharmacology. 2008;33:2200-2205.
-
(2008)
Neuropsychopharmacology
, vol.33
, pp. 2200-2205
-
-
Zhang, X.Y.1
Zhou, D.F.2
Wu, G.Y.3
|